Wikidata

(Q65358479)

English

Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
A Phase 2, Multi-Center, Randomised, Double-Blind, Ascending-Dose, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of Fostamatinib in the Treatment of IgA Nephropathy (English)
0 references
country
Austria
0 references
Germany
0 references
Taiwan
0 references
United Kingdom
0 references
start time
October 2014
0 references
end time
23 March 2018
0 references
number of participants
76
0 references
minimum age
18 year
0 references
maximum age
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65358479&oldid=2236821763"